ES
Seqplexing will be part of a strategic cooperative project for the monitoring of pollutants in the sewage network of Valencia.
The project, in which it will participate together with the Asociación de Investigación de Materiales Plásticos y Conexas (AIMPLAS), the Universidad of València (UV), the Universidad Politécnica of Valencia (UPV) and the company Intercontrol Levante S.A. (INTERCONTROL), was awarded last July with an economic endowment of 138,896 euros and has a planned duration of 3 years.
The Valencian Agency for Innovation (AVI), through the call for Strategic Projects Program in cooperation 2023, funded by the European Union, selected the project "Monitoring of emerging contamin...
Leer másCentro de Desarrollo Tecnológico y la Innovación awards Seqplexing a project in collaboration with Hospital la Fe.
The project in which we are participating together with the Clinical and Translational Research Group in Cardiology of the Hospital Universitario y Politécnico la Fe, was awarded last December with an economic endowment of 292,459 euros and has a planned duration of two years.
The Centro de Desarrollo Tecnológico y la Innovación (CDTI), through the Joint Initiative ISCIII-CDTI (Health Mission Projects), chose our company to participate in a project in collabor...
Leer másSeqplexing participates in international congress organized by the European Society of Human Genetics (ESHG)
Seqplexing has participated in the annual congress organized by the European Society of Human Genetics in Glasgow, presenting preliminary studies on the application of EOSAL-CNV to next generation sequencing (EOSAL-NGS) in a gene panel for the genetic diagnosis of Hereditary Angioedema (HAE)
The Congress took place on June 10-13 in the Scottish city of Glasgow, organized by the European Society of Human Genetics (ESHG). This congress allowed to know the latest news about human genetics in...
Leer másSeqplexing attends Fruit Attraction 2023
On October 3, 4 and 5, the 15th edition of Fruit Attraction was held at IFEMA Madrid, the global benchmark trade fair for the marketing of fruit and vegetables.
Fruit Attraction held its 15th edition on October 3, 4 and 5 at IFEMA Madrid. Invited by Biovegen, Carmen Ivorra, our scientific director, together with our commercial representative, had the opportun...
Leer másSeqplexing presented its CDTI project at the Conference on Personalized Medicine: The evolution of healthcare to improve people's lives.
On October 5th we had the opportunity to present the CDTI project, in which we are participating, during the conference held at the Centro de Investigación Príncipe Felipe by the Ministry of Science and Innovation.
On October 3-6th the Conference on Personalized Medicine: The evolution of health care to improve people's lives was held at the Príncipe Felipe Research Center. These conferences were orga...
Leer másSeqplexing publishes its EOSAL-CNV technology in the book Methods and Molecular Biology
Seqplexing has published a chapter in the Clinical Applications of Nucleic Acid Amplification section of the Methods and Molecular Biology book series.
Last April, Seqplexing had the pleasure of being part of volume 2621 of the Methods and Molecular Biology book series, specifically publishing the protocol "EOSAL-CNV for Easy and Rapid Detection...
Leer másEOSAL, A NEW PROCEDURE FOR CNVs DETECTION. NEW ALTERNATIVE ANALYSIS METHOD VERSUS MLPA.
We developed EOSAL-CNV, a new method based on proportional amplification and labeling of amplicons in 1 PCR.
The EOSAL-CNV procedure allowed reliable CNV detection by a single PCR and fragment analysis in a capillary DNA sequencer. The results, published in Clinical Chemistry,show that EOSAL-CNV r...
Leer másSeqplexing has been the beneficiary of the Innodocto grant, within the program Promotion of talent of Generalitat Valenciana
Seqplexing has been the beneficiary of the Innodocto grant, within the talent promotion program
This aid has been granted by the Valencian Agency for Innovation in the year 2018 and aims to support the strengthening and development of the Valencian Innovation System. The amount of the same wi...
Leer másSeqplexing gets authorization as a health center for genetic diagnosis
Seqplexing has obtained the sanitary authorization to offer services as a genetic diagnosis center
Seqplexing has obtained the sanitary authorization to offer services as a genetic diagnosis center .At Seqplexing laboratory genetic analysis will be carried out to detect point mutations and large...
Leer másSequencing Multiplex participates in the investment forum III Encuentro Capital y Ciencia
Sequencing Multiplex participates in the investment forum III Encuentro Capital y Ciencia
Meeting Capital and Sciencehttp://www.pcuv.es/es/encuentrocapitalyciencia/inicio.html...
Leer másSequencing Multiplex, company of the Parc Científic, awarded in the grants
The Valencian company Sequencing Multiplex S.L. has been selected as beneficiary of the "SEED VLC Emprende" Grants in the 2014 edition, offered by the Innovation and Entrepreneur Projects Delegatio...
Leer más
